Breakthrough study checks HIV drugs Won't harm transplant survival
NCT ID NCT03360682
Summary
This study tested whether a common HIV medication (dolutegravir) works safely alongside anti-rejection drugs in people who have received organ transplants. Researchers followed 19 HIV-positive transplant patients to see if the HIV treatment remained effective without interfering with transplant medications. The goal was to ensure both the transplanted organ and HIV could be managed successfully together.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
Conditions
Explore the condition pages connected to this study.